Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Pre-validation methods for developing a patient reported outcome instrument.

Prior ME, Hamzah JC, Francis JJ, Ramsay CR, Castillo MM, Campbell SE, Azuara-Blanco A, Burr JM.

BMC Med Res Methodol. 2011 Aug 9;11:112. doi: 10.1186/1471-2288-11-112.

2.

Theoretical and empirical dimensions of the Aberdeen Glaucoma Questionnaire: a cross sectional survey and principal component analysis.

Prior M, Ramsay CR, Burr JM, Campbell SE, Jenkinson DJ, Asoaka R, Francis JJ.

BMC Ophthalmol. 2013 Nov 22;13:72. doi: 10.1186/1471-2415-13-72.

3.
4.

Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).

Brettschneider C, L├╝hmann D, Raspe H.

GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092.

5.

Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report.

Rothman M, Burke L, Erickson P, Leidy NK, Patrick DL, Petrie CD.

Value Health. 2009 Nov-Dec;12(8):1075-83. doi: 10.1111/j.1524-4733.2009.00603.x. Epub 2009 Sep 25. Review.

6.
7.

Identifying content for the glaucoma-specific item bank to measure quality-of-life parameters.

Khadka J, McAlinden C, Craig JE, Fenwick EK, Lamoureux EL, Pesudovs K.

J Glaucoma. 2015 Jan;24(1):12-9. doi: 10.1097/IJG.0b013e318287ac11.

PMID:
23552836
8.

[Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].

Reine G, Lancon C, Simeoni MC, Duplan S, Auquier P.

Encephale. 2003 Mar-Apr;29(2):137-47. Review. French.

PMID:
14567165
9.

Development and content validity of a patient reported outcomes measure to assess symptoms of major depressive disorder.

Lasch KE, Hassan M, Endicott J, Piault-Luis EC, Locklear J, Fitz-Randolph M, Pathak S, Hwang S, Jernigan K.

BMC Psychiatry. 2012 Apr 25;12:34. doi: 10.1186/1471-244X-12-34.

10.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
11.

Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients.

Abetz L, Rajagopalan K, Mertzanis P, Begley C, Barnes R, Chalmers R; Impact of Dry Eye on Everyday Life (IDEEL) Study Group.

Health Qual Life Outcomes. 2011 Dec 8;9:111. doi: 10.1186/1477-7525-9-111.

12.

What do self-efficacy items measure? Examining the discriminant content validity of self-efficacy items.

Burrell AMG, Allan JL, Williams DM, Johnston M.

Br J Health Psychol. 2018 Mar 8. doi: 10.1111/bjhp.12306. [Epub ahead of print]

PMID:
29520897
13.

Quality of life of caregivers of children with congenital glaucoma: development and validation of a novel questionnaire (CarCGQoL).

Gothwal VK, Bharani S, Mandal AK.

Invest Ophthalmol Vis Sci. 2015 Jan 15;56(2):770-7. doi: 10.1167/iovs.14-15905.

PMID:
25593027
14.

Choosing appropriate patient-reported outcomes instrument for glaucoma research: a systematic review of vision instruments.

Che Hamzah J, Burr JM, Ramsay CR, Azuara-Blanco A, Prior M.

Qual Life Res. 2011 Sep;20(7):1141-58. doi: 10.1007/s11136-010-9831-1. Epub 2011 Jan 4. Review.

PMID:
21203852
15.

Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force.

Matza LS, Patrick DL, Riley AW, Alexander JJ, Rajmil L, Pleil AM, Bullinger M.

Value Health. 2013 Jun;16(4):461-79. doi: 10.1016/j.jval.2013.04.004.

16.

Development and evaluation of an instrument for the critical appraisal of randomized controlled trials of natural products.

Jurgens T, Whelan AM, MacDonald M, Lord L.

BMC Complement Altern Med. 2009 Apr 23;9:11. doi: 10.1186/1472-6882-9-11.

17.

Development and Content Validity Testing of a Patient-Reported Treatment Acceptance Measure for Use in Patients Receiving Treatment via Subcutaneous Injection.

Tatlock S, Grant L, Spertus JA, Khan I, Arbuckle R, Manvelian G, Sanchez RJ.

Value Health. 2015 Dec;18(8):1000-7. doi: 10.1016/j.jval.2015.09.2937. Epub 2015 Nov 18.

18.

Patient-reported outcome measure for neuromyelitis optica: pretesting of preliminary instrument and protocol for further development in accordance with international guidelines.

Moore P, Jackson C, Mutch K, Methley A, Pollard C, Hamid S, Jacob A.

BMJ Open. 2016 Sep 30;6(9):e011142. doi: 10.1136/bmjopen-2016-011142.

19.
20.

Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.

Hobart J, Cano S, Baron R, Thompson A, Schwid S, Zajicek J, Andrich D.

Mult Scler. 2013 Nov;19(13):1773-83. doi: 10.1177/1352458513483378. Epub 2013 Apr 10.

PMID:
23574800

Supplemental Content

Support Center